EGFR and mucoepidermoid carcinoma: The results from in vitro and in vivo studies have demonstrated that aberrantly activated AREG-EGFR signaling is required for CRTC1-MAML2-positive MEC (mucoepidermoid carcinoma) cell growth and survival.